慢阻肺患者的福音！能倍乐已在华上市！

Both chronic obstructive pulmonary disease and bronchial asthma are common clinical respiratory diseases with a high incidence rate. Bronchial asthma is caused by airway inflammatory reaction, hyperresponsiveness and various allergic reactions, and its clinical manifestations include symptoms such as repeated wheezing and coughing. It is a long-acting cholinergic receptor antagonist. By inhibiting the blocking and receptors, it increases the amount of deep breathing solvents. Not only that, Respimat can also inhibit the inflammatory release factors in the patient's body, slow down the patient's respiratory inflammatory response, ensure that the patient's airway is open for 24 hours, thereby improving the body's lung function, thereby improving the symptoms of dyspnea. Now that Respimat has been launched in China, it can be said to be good news for patients with COPD.

Respimat can effectively prevent the relaxation of lost nerves in patients with chronic obstructive pulmonary disease and enable the nerves to contract smoothly. Therefore, the combined use of Seretide and Respimat has a very powerful effect in the treatment of chronic obstructive pulmonary disease. The combined use of the two drugs can make the patient's bronchi expand and contract more smoothly. It can inhibit the obstruction of airflow caused by inflammation from multiple aspects, reduce the symptoms of hypoxia in patients, inhibit the incidence of complications, and has a good effect on the recovery of patients' health.

For: Respimat only needs to be used once a day, because the drug is effective 24 hours a day. If possible, patients should use the drug at the same time every day as much as possible, and spray it twice during use. Because COPD is a long-term disease, patients need to use Respimat every day rather than waiting until breathing problems occur, but remember that patients should not exceed the recommended dose.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.